The take-private is complete. SEM shares will cease trading on the NYSE and will be deregistered. Traders holding SEM should have already tendered shares for the $16.50 cash consideration. No further trading action is possible in the public market. Monitor for any appraisal rights litigation or post-closing adjustments, but the primary event is concluded.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Select Medical Holdings Corporation (SEM) was acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) in a take-private transaction that closed on June 30, 2026. Shareholders received $16.50 per share in cash, representing an ~18% premium to the unaffected price. The company simultaneously entered into a $1 billion incremental term loan facility to help finance the acquisition. As a result, SEM common stock is being delisted from the NYSE and will be deregistered, with the company becoming a wholly-owned indirect subsidiary of the acquirer.
Key Financial Metrics
Key Facts
- Merger closed on June 30, 2026, effective July 1, 2026 at 12:01 a.m.
- Shareholders received $16.50 per share in cash, valuing the company at approximately $3.9 billion.
- The purchase price represents an ~18% premium over the unaffected share price of $13.98 (Nov 24, 2025) and ~25% over the 90-day VWAP.
- Aggregate purchase price paid for all outstanding shares was approximately $1.7 billion.
- A new $1,000,000,000 Tranche B-3 Term Loan facility was established under the existing credit agreement to fund the acquisition.
- WCAS XIV, L.P. and other investors contributed at least 25% of the total consideration as equity.
- SEM common stock is being delisted from the NYSE and the company will file a Form 15 to suspend SEC reporting obligations.
- Seven directors (William H. Frist, Daniel J. Thomas, Katherine R. Davisson, Parvinderjit S. Khanuja, James S. Ely III, Thomas A. Scully, Marilyn B. Tavenner) resigned; Russell L. Carson, David S. Chernow, and Robert A. Ortenzio now serve as directors.
- Current officers, including Robert A. Ortenzio and Martin F. Jackson, will continue to lead the business.
- The company's certificate of incorporation and bylaws were amended and restated.
Financial Impact
Shareholders received $16.50 per share in cash, a total equity value of approximately $1.7 billion for the public float. The enterprise value is approximately $3.9 billion. A new $1 billion term loan was added to the company's debt structure.
Risk Factors
- Potential appraisal rights litigation from shareholders who dissented and demand fair value above $16.50.
- Integration risk for the newly leveraged company under private equity ownership.
- No further public market liquidity for SEM shares.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-079643 |
| Document: tm2619266d7_ex3-2.htm | 0001104659-26-079643 |
| Document: tm2619266d7_8k.htm | 0001104659-26-079643 |
| Document: tm2619266d7_ex3-1.htm | 0001104659-26-079643 |
| Document: tm2619266d7_ex99-1.htm | 0001104659-26-079643 |
| Document: 0001104659-26-079643-index-headers.html | 0001104659-26-079643 |
| Document: 0001104659-26-079643-index.html | 0001104659-26-079643 |
| Document: 0001104659-26-079643.txt | 0001104659-26-079643 |
Track record
8 reports on SEM
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +1.54% at T+60 after the Mar 3, 2026 report. 3 of 4 went positive at some point.
Filters
- Jul 13, 202618w ago 15-12G Neutral 4/10 No price data
- Jul 1, 202619w ago 25-NSE Neutral 9/10 Entry $16.52 No price data
- Jul 1, 202619w ago 8-K Bullish 8/10 Viewing Entry $16.52 No price data
- Jun 26, 202620w ago 8-K Bullish 7/10 Entry $16.53 No price data
- Apr 30, 202628w ago 8-K Bearish 6/10 Entry $16.38 to $16.51 ▼ −0.81% +4.45% vs SPY
- Apr 15, 202630w ago PREM14A Bullish 8/10 Entry $16.38 to $16.45 ▲ +0.43% −5.62% vs SPY
- Mar 4, 202636w ago DEFA14A Neutral 3/10 Entry $16.25 to $16.29 ▲ +0.25% +4.66% vs SPY
- Mar 3, 202636w ago DEFA14A Bullish 9/10 Entry $16.26 to $16.29 ▲ +0.18% +4.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers